Portfolio
Psylaris: Bringing VR-Powered Trauma Therapy to Ukraine
26.02.2026
Our progress journal.
Team
Carmel van den Berk joins the BVP Health team.
25.02.2026
Deep dive
Turning scarcity into opportunity: a breakthrough for organ donation
10.02.2026
Portfolio
PectCof (NL) secures a positive EFSA scientific opinion for Dutch Gum as a novel food ingredient
27.01.2026
Portfolio
Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229
11.12.2025
Portfolio
Lely invests in Dutch scale-up Grassa
09.12.2025
Portfolio
Exit: Fortimedix Surgical acquired by Medtronic
01.12.2025
Portfolio
Curapath and Cristal Therapeutics Sign Co-Exclusive License of CliCr® Bioconjugation Platform
26.11.2025
Portfolio
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
13.11.2025
Portfolio
Qorium secures €22m investment to accelerate cultivated leather commercialisation
11.11.2025
New deal
Psylaris secures new investment to expand digital mental health solutions across Europe
22.10.2025
Team
BVP 2024 Impact Report Now Available!
14.10.2025
Deep dive
ReSolved Technologies: “Confidence in the product and the partnership!”
06.10.2025
Deep dive
AVL Motion: “Aiming to solve the major challenge: labour shortages!”
02.09.2025
Portfolio
Matisse Pharmaceuticals & EpiDisease receive EU funding for their eHISTOCURE project
26.06.2025
Portfolio
Hy2Care secures €4.5 million in funding to prepare for U.S. clinical trial and commercial expansion
14.05.2025
Portfolio
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
17.04.2025
Portfolio
Grassa Raises €3.6M; Grass Protein Consumption by Humans Draws Closer
19.03.2025
Portfolio
Vivalyx Backed by EIC Accelerator with up to €8.5M to Advance Organ Revitalization Technology
19.02.2025
Team
Pierpaolo Padula joins the BVP Health Team
10.01.2025
Portfolio
Matisse Pharmaceuticals receives BfArM approval to study a prolonged infusion of M6229
24.10.2024
Portfolio
Matisse Pharmaceuticals appoints Prof. Carolyn Calfee to the Scientific Board
22.10.2024
Portfolio
Bio-Engineering scale-up Qorium unveils cultivated leather breakthrough, marking major progress toward commercialization
15.10.2024
Portfolio
PL BioScience closes €7.8M Series A Financing
08.08.2024